ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ASH 2023
ecancer
PERSEUS Trial Summary: Adding Daratumumab to VRd as a Frontline Therapy for Newly Diagnosed MM
FEATURING
Pieter Sonneveld
- 193 views
- March 5, 2024
- 2
ecancer
ASH 2023 Insights: "Ilyad Trial - Vitamin D Intervention in Patients With Low Tumor-Burden iNHL Treated With Rituximab"
FEATURING
Jonathan Friedberg
- 48 views
- January 24, 2024
ecancer
ASH 2023 Insights: "PhALLCON Study - Ponatinib vs. Imatinib in Patients With Newly Diagnosed Ph+ ALL"
FEATURING
Elias Jabbour
- 54 views
- January 19, 2024
ecancer
ASH 2023 Insights: "BrECADD Combined With PET2-Guided Treatment for 1L Adult Pts With Advanced Stage cHL"
FEATURING
Peter Borchmann
- 44 views
- January 19, 2024
ecancer
ASH 2023 Insights: "Updates From the Beat AML Master Trial - A Precision Medicine Approach to AML"
FEATURING
Ashley Yocum
- 32 views
- January 19, 2024
ecancer
ASH 2023 Insights: "Niveau Trial - Nivolumab + R-GemOx Followed by Nivo Maintenance in R/R LBCL"
FEATURING
Gerhard Held
- 45 views
- January 18, 2024
ecancer
ASH 2023 Insights: "KarMMa-3 Study - HRQoL With Ide-Cel Treatment in Patients With R/R MM"
FEATURING
Michel Delforge
- 13 views
- January 18, 2024
ecancer
ASH 2023 Insights: "AUGMENT-101 - Revumenib Monotherapy in Pts With R/R KMT2Ar Acute Leukemia"
FEATURING
Ibrahim Aldoss
- 55 views
- January 18, 2024
- 1